ProShare Advisors
KNSA icon

ProShare Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History

ProShare Advisors’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,225
Closed -$227K – 2134
2025
Q1 		$227K Sell
10,225
-2,582
-20% -$53.1K ﹤0.01% 1602
2024
Q4 		$253K Buy
12,807
+3,357
+36% +$76.6K ﹤0.01% 1759
2024
Q3 		$236K Buy
+9,450
New +$230K ﹤0.01% 1631
2022
Q1 		– Sell
-11,143
Closed -$131K – 2255
2021
Q4 		$131K Buy
11,143
+433
+4% +$5.32K ﹤0.01% 2156
2021
Q3 		$122K Sell
10,710
-2,664
-20% -$34.7K ﹤0.01% 1884
2021
Q2 		$186K Buy
13,374
+1,814
+16% +$27.6K ﹤0.01% 2166
2021
Q1 		$214K Buy
11,560
+754
+7% +$15.4K ﹤0.01% 2001
2020
Q4 		$191K Buy
+10,806
New +$190K ﹤0.01% 1858

Other funds holding KNSA

RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return